Exai Bio logo

Exai Bio Funding & Investors

Exai Bio is a next-generation liquid biospy company. Exai bio proprietary RNA and artificial intelligence-based liquid biopsy platform deliver clinical insights into cancer biology to enable the earliest, most accurate diagnosis of cancer.

exai.bio

Total Amount Raised: $67,500,000

Exai Bio Funding Rounds

  • Series A

    $67,500,000

    Series A Investors

    Two Sigma Ventures
    Section 32
    Casdin Capital
Funding info provided by Diffbot.